FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

URGENT REQUEST for Product QUARANTINE of Immune Globuline Intravenous (Human)

horizontal rule

DATE QUARANTINE INITIATED:

June 11, 1999

PRODUCT / LOT NUMBER / EXPIRATION DATE:

Immune Globulin Intravenous (Human), Venoglobulin-S, 10% solution:

GR9035A 04/04/2001
GR9036A 04/06/2001

MANUFACTURER:

Alpha Therapeutic Corporation
Los Angeles, CA

REASON:

Alpha Therapeutic Corporation is requesting that all stock of the above mentioned lots be held in quarantine until further notice. This action is being taken because post-manufacturing visual inspection detected microbial contamination in a single vial from two other lots of Immune Globulin Intravenous. All products filled in the same area during the same time period passed sterility testing, including lots GR9035A and GR9036A. However, Alpha has determined that this cautionary quarantine is prudent to insure patient safety until their investigation is completed.

horizontal rule

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

 

 
horizontal rule